Literature DB >> 8971434

Proguanil metabolism in relation to S-mephenytoin oxidation in a Turkish population.

N E Basci1, A Bozkurt, S Kortunay, A Isimer, A Sayal, S O Kayaalp.   

Abstract

The oxidation of proguanil was studied in 89 unrelated healthy Turkish volunteers after administration of proguanil (single dose, 200 mg, orally). Based on the distribution of the ratio of proguanil to cycloguanil excreted in urine, and using an antimode value of 15, the prevalence of poor metabolizers in a Turkish population was estimated to be 5.6% (95% confidence interval 2.0%-17.3%) which was similar to that in the other Caucasian populations. The relationship between the oxidative capacities of CYP2C19 for the two substrates, proguanil and mephenytoin, was studied in 39 subjects (two poor and 37 extensive metabolizers of proguanil). The two poor metabolizers of proguanil were also identified as poor metabolizers of S-mephenytoin and no misclassification by the two phenotyping methods was observed. The correlation between the metabolic ratio of proguanil to cycloguanil and the S/R-mephenytoin ratio as assessed by Spearman's rank test, was statistically significant (rs = 0.50, P < 0.001).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8971434      PMCID: PMC2042714          DOI: 10.1046/j.1365-2125.1996.00500.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  6 in total

1.  Evaluation of lansoprazole as a probe for assessing cytochrome P450 2C19 activity and genotype-phenotype correlation in childhood.

Authors:  Ersin Gumus; Ozgur Karaca; Melih O Babaoglu; Gökhan Baysoy; Necati Balamtekin; Hulya Demir; Nuray Uslu; Atilla Bozkurt; Aysel Yuce; Umit Yasar
Journal:  Eur J Clin Pharmacol       Date:  2011-11-11       Impact factor: 2.953

Review 2.  Interethnic variation of CYP2C19 alleles, 'predicted' phenotypes and 'measured' metabolic phenotypes across world populations.

Authors:  I Fricke-Galindo; C Céspedes-Garro; F Rodrigues-Soares; M E G Naranjo; Á Delgado; F de Andrés; M López-López; E Peñas-Lledó; A LLerena
Journal:  Pharmacogenomics J       Date:  2015-10-27       Impact factor: 3.550

3.  The effect of polymorphic metabolism enzymes on serum phenytoin level.

Authors:  Aydan Ozkaynakci; Medine Idrizoglu Gulcebi; Deniz Ergeç; Korkut Ulucan; Mustafa Uzan; Cigdem Ozkara; Ilter Guney; Filiz Yilmaz Onat
Journal:  Neurol Sci       Date:  2014-10-14       Impact factor: 3.307

4.  CYP2C19 genotype does not represent a genetic predisposition in idiopathic systemic lupus erythematosus.

Authors:  S Kortunay; A Bozkurt; L Bathum; N E Basci; M Calgüneri; K Brøsen; S O Kayaalp
Journal:  Ann Rheum Dis       Date:  1999-03       Impact factor: 19.103

Review 5.  Clinical relevance of genetic polymorphisms in the human CYP2C subfamily.

Authors:  J A Goldstein
Journal:  Br J Clin Pharmacol       Date:  2001-10       Impact factor: 4.335

6.  Concordance between proguanil phenotype and CYP2C19 genotype in Chinese.

Authors:  Janelle M Hoskins; Gillian M Shenfield; Annette S Gross
Journal:  Eur J Clin Pharmacol       Date:  2003-09-12       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.